Biopharma companies are increasingly turning to artificial intelligence (AI) to enhance customer-focused commercial strategies, driving more tailored engagement and improved operational eff
In 2020, commercial leadership at EVERSANA, well versed in the transformation of the contract research organisation (CRO) sector, believed that the often slow-to-pivot pharmaceutical indust
Established brands represent the majority of portfolios across pharma’s global affiliates that are often neglected, with revenue and profit growth untapped.
Oliver Stohlmann’s Corporate Survival Hacks series draws on experiences of working in local, regional, and global life sciences communications to offer some little tips for enjoying a big b
‘Cyber-chondria’ has become an endemic part of our daily lives since the term - which describes people who search online to understand symptoms and improve their health - was coined in